181 related articles for article (PubMed ID: 8334634)
1. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.
Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Terakawa N
Cancer; 1993 Aug; 72(3):804-8. PubMed ID: 8334634
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA ploidy and S-phase fraction in malignant serous cystadenocarcinoma of the ovary.
Bakshi N; Rajwanshi A; Patel F; Ganguly NK
Anal Quant Cytol Histol; 1998 Jun; 20(3):215-20. PubMed ID: 9642449
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
4. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
Fu YS; Ro J; Reagan JW; Hall TL; Berek J
Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
[TBL] [Abstract][Full Text] [Related]
5. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance.
Kimball RE; Schlaerth JB; Kute TE; Schlaerth AC; Santoso J; Ballon SC; Spirtos NM
Am J Obstet Gynecol; 1997 Jun; 176(6):1319-26; discussion 1326-7. PubMed ID: 9215191
[TBL] [Abstract][Full Text] [Related]
8. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
11. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
14. Cellular DNA content and survival in advanced ovarian carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
16. Cytofluorometric analysis of the DNA content in ovarian carcinoma and its relationship to patient survival.
Murray K; Hopwood L; Volk D; Wilson JF
Cancer; 1989 Jun; 63(12):2456-60. PubMed ID: 2720595
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral DNA heterogeneity correlated with lymph node involvement and surgical staging in epithelial ovarian cancer by flow cytometry.
Takahashi Y; Takenaka A; Ishiguro T; Noda Y
Cancer; 1994 Jun; 73(12):3011-4. PubMed ID: 8199997
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy analysis of mucinous cystic tumors of the pancreas. Correlation of aneuploidy with malignancy and poor prognosis.
Southern JF; Warshaw AL; Lewandrowski KB
Cancer; 1996 Jan; 77(1):58-62. PubMed ID: 8630940
[TBL] [Abstract][Full Text] [Related]
19. Correlation of DNA ploidy and clinical outcome in Borrmann type 4 gastric carcinoma.
Yonemura Y; Sugiyama K; Fujimura T; Kamata T; Kosaka T; Fushida S; Yamaguchi A; Miwa K; Miyazaki I
J Surg Oncol; 1989 Sep; 42(1):1-4. PubMed ID: 2770304
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]